Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS INTL

Security class unavailable · CUSIP: G52694109

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,582,635
Percent of class
3.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006617
Form type
SC 13G/A
Filer
HHLR ADVISORS, LTD.
CIK
CIK 1762304
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub